In contrast, similar to MTX-treated rats, AIA rats injected with AAV-TREX1 in either the knee joint cavity or tail vein showed significant decreases in the arthritis score and hind paw volume, suggesting that the severity of AIA was markedly attenuated in rats with overexpression of TREX1. The gene discussed is TREX1; the disease is arthritic joint disease.